MedCrunch

A new kind of online magazine covering health, medicine, entrepreneurship and technology all centered around new trends and the challenge of being a physician

Pharma
5 Elements Of A Pharma Company 2.0

5 Elements Of A Pharma Company 2.0

In various posts we have been calling for a change within the pharmaceutical industry. Much of that is not new, yet still nothing seems to change on a bigger scale. Sure, the iPad is becoming an essentiell tool in sales, eDetails have emerged, biotech startups are being bought instead of inhouse R&D, but especially with...
Pharma Should Acquire Software Startups

Pharma Should Acquire Software Startups

The pharmaceutical industry has been dormant throughout the last decades when it comes to finding new business and sales models. The big ones have been keen on keeping competitors out of their businesses by close surveillance or legal action. In order to sustain and grow their revenue, the pharmaceutical industry has one of the most...
What is Pharma's Sales Savior?

What is Pharma’s Sales Savior?

We've previously reported several times on the interaction between physicians and pharmaceutical companies. We've also argued to some extent the model is dead. Pharma reps are expensive and pharma has transitioned into a sales business,...
Doctors Know Sh*t

Doctors Know Sh*t

OK, this is a controversial headline, but it’s true – to some extent and in regards to certain things. We are not speaking of the medical profession obviosuly but from all these things that you, as a human being in the civilized world are surrounded with. In med school and as a physician you are...
Interview with Abbott's Diabetes Head Asia Pacific: Andreas Amrein

Interview with Abbott’s Diabetes Head Asia Pacific: Andreas Amrein

After we’ve had an interview with the amazing and insightful Dr. Bryan Vartebedian as well as the inspirational Lisa Chu, we thought that we should also talk to somebody who’s on the pharma side of the healthcare industry. Dr. Andreas Amrein, who is the Senior Area Director for the Diabetes Unit of Abbott in Asia...
Who Owns the Content? The Future of Medical Publishing.

Who Owns the Content? The Future of Medical Publishing.

Education is one of MedCrunch’s favorite topics. These are great times to talk about education. The internet and mobile devices have liberated knowledge and democratized its distribution. Up until now, medical knowledge was owned or distributed by several entities: the experts who produce it, the universities, the publishers and the various medical societies. Moreover, the...
The Push and Pull of Pharma Marketing and What Physicians Can Do About it.

The Push and Pull of Pharma Marketing and What Physicians Can Do About it.

Pharmaceutical marketing that is directed towards physicians is called "push-marketing". Marketing directed towards patients is called "pull-marketing"...
The Truth about Placebos and Why You Should Care

The Truth about Placebos and Why You Should Care

Placebos are pivotal to modern medical research and practice. We've found this amazing video and some interesting facts.
Pharma Marketing is Dead! Long Live Pharma Marketing!

Pharma Marketing is Dead! Long Live Pharma Marketing!

The marketing approach of most pharmaceutical companies is very old-fashioned, to put it politely. It's time for a change - we think.
Register For Europe's Leading E-Health Event For Docs

Register For Europe’s Leading E-Health Event For Docs

If you are into tech and medicine then you probably already noticed that there are quite some conferences out there that cover these areas. Now most of these conferences though are not that interesting if you are a practicing physician.
Package Design For Drugs Does Matter

Package Design For Drugs Does Matter

In this post, Lukas explains how drug packaging can make medicine safer and more enjoyable.
Pharma Marketing 101: Two Things Pharma Needs From You

Pharma Marketing 101: Two Things Pharma Needs From You

“Pharma-marketing” is a taboo term for many physicians. Many of our colleagues view it as a discipline characterized by a plethora of unethical actions...